Azarest 300 mg (Azarest) Tablets

AZAREST 300 mg (Azacitidine) is an antineoplastic medicine used in the treatment of specific bone marrow disorders and blood cancers. It works by helping restore normal growth and development of blood cells while reducing the proliferation of abnormal cells in the bone marrow.

Therapeutic Benefits:

• Management of Myelodysplastic Syndromes (MDS)
• Treatment of selected patients with Acute Myeloid Leukemia (AML)
• Helps improve blood cell production in the bone marrow
• Reduces dependence on blood transfusions in eligible patients
• Supports better control of abnormal hematopoietic cell growth
• May help delay disease progression in certain hematologic conditions
• Contributes to improved overall disease management when used under specialist supervision

Generic Name: Azacitidine

Strength: 300 mg

Dosage Form: Tablet

Composition:
Each film-coated tablet contains:

• Azacitidine USP – 300 mg

Pharmacological Class:

• DNA Methyltransferase Inhibitor
• Hypomethylating Agent
• Antineoplastic Agent

Azacitidine is a nucleoside metabolic inhibitor that helps regulate abnormal gene expression and promotes the restoration of normal cellular function within the bone marrow.

AZAREST should be taken strictly according to the instructions of a qualified oncology or hematology specialist.

Recommended Administration:

• Take the tablet exactly as prescribed by your healthcare provider.
• Swallow the tablet whole with a glass of water.
• Do not crush, chew, or split the tablet unless advised by a physician.
• The medicine may be taken with or without food.
• Treatment schedules and duration depend on the patient's medical condition, response to therapy, and laboratory monitoring results.

Missed Dose:

• If a dose is missed, take it as soon as remembered on the same day.
• If it is almost time for the next scheduled dose, skip the missed dose and continue the regular schedule.
• Do not take a double dose to compensate for a missed dose.

Important Instructions:

• Regular blood count monitoring is required during treatment.
• Follow all scheduled medical appointments and laboratory assessments.
• Do not discontinue therapy without consulting your healthcare provider.
• Use only under the supervision of an experienced oncology specialist.